Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services.
Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services.
复制标题
DOI：
10.1016/j.puhe.2021.01.004
复制
发表时间：
2021-03
期刊：
影响因子：
5.2
通讯作者：
Phipps E
中科院分区：
文献类型：
--
作者：
Croxford S;Emanuel E;Ibitoye A;Njoroge J;Edmundson C;Bardsley M;Heinsbroek E;Hope V;Phipps E
这项研究的目的是描述严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行对英格兰、威尔士和北方爱尔兰注射毒品者（PWID）的影响。这是一项针对PWID的跨部门无关联匿名监测（UAM）调查。曾经注射过精神活性药物的人被英格兰、威尔士和北方爱尔兰的专业药物/酒精服务机构招募到UAM调查中。从2020年6月起，除了提供干血斑样本和填写UAM行为问卷外，参与者还被要求填写一份增强型2019冠状病毒病（COVID-19）问卷。初步数据截至10月底，并在可能的情况下与2019年UAM调查的数据进行了比较。6月至10月间，从英格兰和北方爱尔兰招募了288名PWID。九分之一（11%; 29/260）的PWID报告SARS-CoV-2检测呈阳性或出现COVID-19症状。15%（26/169）的人报告说，2020年的注射频率比2019年更高;前四周的可卡因注射从17%（242/1456）增加到25%（33/130）。五分之一（19%; 35/188）的PWID报告难以获得艾滋病毒和肝炎检测，四分之一（26%; 47/179）的PWID报告难以获得安全注射设备。我们的初步调查结果显示，由于COVID-19大流行，PWID对健康、行为以及获得基本的减少伤害、检测和治疗服务产生了负面影响。需要通过监测和研究进行持续监测，以了解COVID-19对这一人群中血液传播病毒传播和健康不平等的后续影响。
The aim of the study was to describe the impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic on people who inject drugs (PWID) in England, Wales and Northern Ireland. This is a cross-sectional Unlinked Anonymous Monitoring (UAM) Survey of PWID. People who had ever injected psychoactive drugs were recruited to the UAM Survey by specialist drug/alcohol services in England, Wales and Northern Ireland. From June 2020, in addition to providing a dried blood spot sample and completing the UAM behavioural questionnaire, participants were asked to complete an enhanced coronavirus disease 2019 (COVID-19) questionnaire. Preliminary data are presented to the end of October and were compared with data from the 2019 UAM Survey, where possible. Between June and October, 288 PWID were recruited from England and Northern Ireland. One in nine (11%; 29/260) PWID reported testing positive for SARS-CoV-2 or experiencing COVID-19 symptoms. Fifteen percent (26/169) reported injecting more frequently in 2020 than in 2019; cocaine injection in the preceding four weeks increased from 17% (242/1456) to 25% (33/130). One in five PWID (19%; 35/188) reported difficulties in accessing HIV and hepatitis testing, and one in four (26%; 47/179) reported difficulties in accessing equipment for safer injecting. Our preliminary findings suggest that PWID have experienced negative impacts on health, behaviours and access to essential harm reduction, testing and treatment services owing to the COVID-19 pandemic. Continued monitoring through surveillance and research is needed to understand the subsequent impact of COVID-19 on blood-borne virus transmission in this population and on health inequalities.
影响因子：
4.2
作者：
Welle-Strand GK;Skurtveit S;Clausen T;Sundal C;Gjersing L
通讯作者：
Gjersing L
影响因子：
4.4
作者：
Whitfield, Mark;Reed, Howard;Hope, Vivian
通讯作者：
Hope, Vivian
影响因子：
6
作者：
Vasylyeva, Tetyana, I;Smyrnov, Pavlo;Friedman, Samuel R.
通讯作者：
Friedman, Samuel R.